Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma

Rosaria Santangelo, Francesco D'Alo', Maurizio Pompili, Stefan Hohaus, Maria Chiara Tisi, Elisa Cupelli, Elena Maiolo, Eleonora Alma, Manuela Giachelia, Maurizio Martini, Silvia Bellesi, Maria Teresa Voso, Giuseppe Leone, Luigi Maria Larocca

Risultato della ricerca: Contributo in rivistaArticolo in rivista

14 Citazioni (Scopus)

Abstract

An association between Epstein-Barr Virus (EBV) infection and lymphoproliferative diseases has been reported with EBV + diffuse large B cell-lymphoma (DLBCL) of the elderly described as a distinct entity. In a cohort of 218 human immunodeficiency virus (HIV)-negative patients with diffuse large B-cell lymphomas, we detected EBV-DNA in 25% of whole blood (WB) samples at diagnosis. Presence and viral load in WB, mononuclear cells or plasma did not predict the presence of EBV in the tumor biopsy. Positive Hepatitis C virus (HCV) serology was associated with a higher frequency of EBV in WB. Patients with EBV-DNA in WB had a significantly shorter progression-free (p = 0.02) and overall survival (p = 0.05) after immunochemotherapy with R-CHOP (Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, Prednisolone). We conclude that detection of EBV in WB is not a surrogate marker for EBV-association in diffuse large B-cell lymphoma, however it associates with worse outcome.
Lingua originaleEnglish
pagine (da-a)628-634
Numero di pagine7
RivistaLEUKEMIA & LYMPHOMA
Volume57
DOI
Stato di pubblicazionePubblicato - 2016

Keywords

  • Diffuse large B-cell lymphoma
  • EBV
  • prognosis

Fingerprint

Entra nei temi di ricerca di 'Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma'. Insieme formano una fingerprint unica.

Cita questo